Linguamatics and RealHealthData Partner to Extract Real World Evidence from Patient Narratives

  • Date 3 Aug 2017

NLP text mining transforms medical transcripts data into insights for better patient care

Understanding the real world (i.e., outside of clinical trials) impact of therapies on patients is critical for pharmaceutical and biotech companies. Medical records are one of the key sources of real world data, and provide evidence that can inform all phases of drug development. RealHealthData provides access to patient narratives from all 50 US states and every medical specialty. The data can be used for all phases of drug development and post marketing research. Linguamatics I2E can be used to extract the key facts from these narratives using relevant ontologies and queries, transforming real world data into actionable intelligence for better decision making.

“Deploying Linguamatics I2E Advanced NLP engine to the RealHealthData database of detailed provider narratives is a natural fit,” said Manuel Prado, CEO of RealHealthData. “Current and future customers can now access the unique and valuable insights in the database using a first-in-class, healthcare-specific Natural Language Processing platform.”

The unstructured text of EHRs and patient records provides a level of detail and granularity not available from the structured fields that life science companies usually work with. RealHealthData’s database of patient narratives contains detailed records that include valuable information that could impact patient outcomes, such as patient social status, and detailed clinical characteristics (comorbidities, complications, co-medications, lab values, adherence or switching issues).

David Milward, CTO of Linguamatics, said “Using I2E we can search this huge amount of unstructured patient data using NLP, incorporating machine learning to directly find patients of interest (e.g. diabetic patients who smoke and have a weight over 80kg), and use the longitudinal data to look at outcomes or behaviour over time.”

“We believe this partnership will enhance the value we can provide our life science customers for health economics and outcomes research, epidemiology, and medical affairs. We look forward to working with RealHealthData as we explore additional opportunities to improve the use of Real World Evidence,” said Jane Reed, Head of Life Science Strategy at Linguamatics.


About RealHealthData

Linguamatics Media contact:

Michelle Ronan Noteboom, Sr. Account Director

Amendola Communications

+ 1 512.426.2870


RealHealthData Media contact:

Philip Howell, Director


+1 904.572.0229

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more